IntegraGen SA (EPA:ALINT)
France flag France · Delayed Price · Currency is EUR
0.2590
-0.1020 (-28.25%)
May 14, 2026, 5:35 PM CET

IntegraGen Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
5.028.712.5413.1711.32
Other Revenue
0.31-0.070.04-
5.338.712.613.2111.32
Revenue Growth (YoY)
-38.67%-30.99%-4.57%16.63%25.82%
Cost of Revenue
3.966.867.377.83-
Gross Profit
1.381.845.235.3811.32
Selling, General & Admin
3.392.934.835.15-
Other Operating Expenses
0.61-0.340.180.1711.15
Operating Expenses
4.042.655.25.5211.37
Operating Income
-2.66-0.810.03-0.14-0.04
Interest Expense
-0--0.01-0.01-
Interest & Investment Income
0.040.140.060.010.13
Other Non Operating Income (Expenses)
000.04-0-
EBT Excluding Unusual Items
-2.62-0.670.13-0.140.08
Gain (Loss) on Sale of Investments
-0.01--0.060.07-
Gain (Loss) on Sale of Assets
-0.12-0.02-0.06-
Other Unusual Items
-0.31-0.35-0.01-
Pretax Income
-2.76-0.35-0.26-0.140.08
Income Tax Expense
-0.09-0.1-0.09-0.140.07
Net Income
-2.66-0.26-0.17-00.02
Net Income to Common
-2.66-0.26-0.17-00.02
Shares Outstanding (Basic)
--77-
Shares Outstanding (Diluted)
--77-
Shares Change (YoY)
---0.22%--
EPS (Basic)
---0.03-0.00-
EPS (Diluted)
---0.03-0.00-
Free Cash Flow
-1.58----
Gross Margin
25.78%21.19%41.53%40.74%100.00%
Operating Margin
-49.93%-9.29%0.26%-1.05%-0.39%
Profit Margin
-49.93%-2.94%-1.36%-0.03%0.13%
Free Cash Flow Margin
-29.58%----
EBITDA
-2.62-0.750.230.060.17
EBITDA Margin
-49.10%-8.63%1.83%0.47%1.50%
D&A For EBITDA
0.040.060.20.20.21
EBIT
-2.66-0.810.03-0.14-0.04
EBIT Margin
-49.93%-9.29%0.26%-1.05%-0.39%
Effective Tax Rate
----81.71%
Revenue as Reported
10.369.0412.8313.511.55
Source: S&P Global Market Intelligence. Standard template. Financial Sources.